Neuroscience

Our neuroscience therapeutic area is driven by the immense unmet need of patients with diseases of the central nervous system.  Our mission is to bring innovative medicines to patients suffering from neurologic and psychiatric diseases for whom there are no treatments available. To deliver on this mission, our approach leverages advances in molecularly and genetically defined targets, biomarkers and targeted modalities.  Our commitment to helping patients extends beyond our research efforts by supporting several neuroscience patient and provider organizations to help raise awareness, educate patients and their families, and broaden access to therapies.

Disease areas

Major Depressive Disorder (MDD)
MDD, also known as depression, is a complex mental health illness that is the leading cause of disability worldwide and a major contributor to the overall global burden of disease. MDD may trigger emotional, cognitive and physical symptoms, which includes depressed mood, loss of interest or pleasure, significant weight loss or gain or change in appetite, insomnia or hypersomnia, psychomotor agitation or retardation, fatigue or loss of energy, feelings of worthlessness or excessive guilt, diminished ability to think or concentrate, or indecisiveness, and recurrent suicidal ideation.

Attention-Deficit Hyperactivity Disorder (ADHD)
ADHD is one of the most common neurobehavioral disorders in children. The key feature of ADHD is a repeated pattern of inattention and or hyperactivity that interferes with functioning or development. Although many people tend to think of ADHD as a childhood problem, nearly 50 percent of children with ADHD may continue to meet the criteria for the disorder in adulthood.

Binge Eating Disorder (B.E.D.)
B.E.D. is the most common eating disorder in U.S. adults and is more prevalent than anorexia and bulimia combined. B.E.D. occurs in both men and women, is seen across racial and ethnic groups, and can occur in normal weight, overweight and obese adults. B.E.D. is defined as recurring episodes, on average, at least once weekly, for three months, of consuming a large amount of food in a short time, compared with what others would consume under the same or similar circumstances. Patients feel a lack of control over eating during a binge eating episode and can become very upset over their binge eating.



Related Content